Phosphate binder use, last 1 month |
Total N | N | Weighted % | ||
---|---|---|---|---|
National sample | Month | |||
Overall | MAY15 | 10,444 | 8,177 | 83.9% |
JUN15 | 10,912 | 8,507 | 82.6% | |
JUL15 | 11,545 | 8,930 | 82.1% | |
AUG15 | 11,484 | 8,937 | 82.6% | |
SEP15 | 11,465 | 8,938 | 82.9% | |
OCT15 | 11,533 | 8,974 | 82.7% | |
NOV15 | 11,774 | 9,112 | 82.9% | |
DEC15 | 11,615 | 9,038 | 83.0% | |
JAN16 | 11,567 | 9,033 | 83.0% | |
FEB16 | 11,697 | 9,092 | 82.4% | |
MAR16 | 11,964 | 9,281 | 82.5% | |
APR16 | 11,830 | 9,275 | 82.8% | |
MAY16 | 11,781 | 9,292 | 83.2% | |
JUN16 | 11,755 | 9,305 | 83.6% | |
JUL16 | 11,747 | 9,268 | 83.8% | |
AUG16 | 11,466 | 9,169 | 84.0% | |
SEP16 | 11,315 | 9,082 | 84.1% | |
OCT16 | 11,263 | 9,040 | 84.3% | |
NOV16 | 11,396 | 9,112 | 84.3% | |
DEC16 | 11,173 | 9,006 | 84.9% | |
JAN17 | 11,097 | 8,921 | 84.1% | |
FEB17 | 11,058 | 8,834 | 83.9% | |
MAR17 | 11,204 | 8,912 | 84.6% | |
APR17 | 11,121 | 8,927 | 85.1% | |
MAY17 | 11,098 | 8,934 | 84.3% | |
JUN17 | 11,158 | 8,930 | 82.7% | |
JUL17 | 11,352 | 9,007 | 83.4% | |
AUG17 | 11,074 | 8,879 | 84.6% | |
SEP17 | 10,952 | 8,816 | 83.6% | |
OCT17 | 10,923 | 8,773 | 83.6% | |
NOV17 | 11,096 | 8,833 | 84.0% | |
DEC17 | 10,995 | 8,767 | 84.4% | |
JAN18 | 10,933 | 8,737 | 84.7% | |
FEB18 | 10,998 | 8,760 | 84.2% | |
MAR18 | 13,248 | 10,352 | 79.5% | |
APR18 | 10,223 | 7,841 | 77.6% | |
MAY18 | 10,662 | 8,163 | 77.6% | |
JUN18 | 11,065 | 8,454 | 77.7% | |
JUL18 | 11,455 | 8,699 | 77.2% | |
AUG18 | 11,876 | 9,036 | 77.4% | |
SEP18 | 12,417 | 9,411 | 77.4% | |
OCT18 | 12,288 | 9,362 | 77.4% | |
NOV18 | 12,137 | 9,296 | 77.6% | |
DEC18 | 11,958 | 9,234 | 78.2% | |
JAN19 | 11,912 | 9,199 | 78.5% | |
FEB19 | 11,934 | 9,176 | 78.4% | |
MAR19 | 12,144 | 9,384 | 78.9% | |
APR19 | 11,987 | 9,369 | 79.6% | |
MAY19 | 11,864 | 9,314 | 79.9% | |
JUN19 | 12,251 | 9,524 | 78.3% | |
JUL19 | 12,727 | 9,824 | 77.4% | |
AUG19 | 12,744 | 9,899 | 77.1% | |
SEP19 | 13,280 | 10,324 | 76.9% | |
OCT19 | 12,980 | 10,155 | 77.2% | |
NOV19 | 12,745 | 10,010 | 76.9% | |
DEC19 | 12,673 | 9,966 | 76.8% | |
JAN20 | 12,640 | 9,946 | 76.6% | |
FEB20 | 12,502 | 9,877 | 77.3% | |
MAR20 | 12,686 | 10,079 | 77.6% | |
APR20 | 12,428 | 9,967 | 78.1% | |
MAY20 | 12,284 | 9,886 | 78.4% | |
JUN20 | 12,183 | 9,795 | 78.2% | |
JUL20 | 12,235 | 9,848 | 78.6% | |
AUG20 | 12,140 | 9,798 | 78.4% | |
SEP20 | 12,172 | 9,810 | 78.7% | |
OCT20 | 11,945 | 9,687 | 78.7% | |
NOV20 | 11,785 | 9,559 | 78.9% | |
DEC20 | 11,661 | 9,441 | 78.8% | |
JAN21 | 11,645 | 9,432 | 78.7% | |
FEB21 | 10,598 | 8,565 | 79.7% |
Values for each month reflect prescription at end of study month (2010, 2011) or anytime during study month (2012+) |
Facility sample transitioned from DOPPS 4 to 5 in Jan-Apr 2012 (see "Study Sample and Methods"). |
Facility sample transitioned from DOPPS 5 to 6 in Mar-Jul 2015 (see "Study Sample and Methods"). |
Facility sample transitioned from DOPPS 6 to 7 in Feb-May 2018 (see "Study Sample and Methods"). |
Source: US-DOPPS Practice Monitor, May 2021; http://www.dopps.org/DPM |